Dermatoglyphics in hypertension: a review
- PMID: 26265377
- PMCID: PMC4534102
- DOI: 10.1186/s40101-015-0065-3
Dermatoglyphics in hypertension: a review
Abstract
Hypertension is a major contributor to the global burden of disease and mortality. A major medical advancement would be a better means to ascertain which persons are at higher risk for becoming hypertensive beforehand. To that end, there have been a number of studies showing that certain dermatoglyphic markers are associated with hypertension. This association could be explained if the risk toward developing hypertension later on in life is somehow connected with fetal development of dermatoglyphics. It would be highly valuable from a clinical standpoint if this conjecture could be substantiated since dermatoglyphic markers could then be used for screening out individuals who might be at an elevated risk of becoming hypertensive. The aim of this review was to search for and appraise available studies that pertain to the association between hypertension and dermatoglyphics.A systematic literature search conducted using articles from MEDLINE (PubMed), Trip, Cochran, Google scholar, and gray literature until December 2014. Of the 37 relevant publications, 17 were included in the review. The review performed according to the preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement.This review showed a fairly consistent finding of an increased frequency of whorl patterns along with a higher mean total ridge count in digital dermatoglyphic results in hypertensive samples compared to controls. However, it was imperative to discuss several limitations found in the studies that could make this association as yet unsettled.
Figures
Similar articles
-
Dermatoglyphics in kidney diseases: a review.Springerplus. 2016 Mar 8;5:290. doi: 10.1186/s40064-016-1783-7. eCollection 2016. Springerplus. 2016. PMID: 27066327 Free PMC article. Review.
-
The status of dermatoglyphics as a biomarker of Tel Hashomer camptodactyly syndrome: a review of the literature.J Med Case Rep. 2016 Sep 20;10(1):258. doi: 10.1186/s13256-016-1048-7. J Med Case Rep. 2016. PMID: 27650795 Free PMC article. Review.
-
On the association between adult blood pressure and dermatoglyphics as prenatal markers of development.J Hypertens. 1995 Jun;13(6):595-601. doi: 10.1097/00004872-199506000-00004. J Hypertens. 1995. PMID: 7594415
-
Correlation of palatal anatomic characteristics with dermatoglyphic heterogeneity in different growth patterns.Morphologie. 2024 Sep;108(362):100775. doi: 10.1016/j.morpho.2024.100775. Epub 2024 Mar 21. Morphologie. 2024. PMID: 38518579
-
Dermatoglyphics in juvenile hypertension.Anthropol Anz. 1991 Dec;49(4):361-6. Anthropol Anz. 1991. PMID: 1793261
Cited by
-
Dermatoglyphics and Cheiloscopy patterns in hypertensive and type 2 Diabetes mellitus patients: An observational study.J Family Med Prim Care. 2021 Mar;10(3):1177-1182. doi: 10.4103/jfmpc.jfmpc_1986_20. Epub 2021 Apr 8. J Family Med Prim Care. 2021. PMID: 34041147 Free PMC article.
-
Dermatoglyphics in kidney diseases: a review.Springerplus. 2016 Mar 8;5:290. doi: 10.1186/s40064-016-1783-7. eCollection 2016. Springerplus. 2016. PMID: 27066327 Free PMC article. Review.
-
A "Handy" tool for hypertension prediction: Dermatoglyphics.Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S116-S119. doi: 10.1016/j.ihj.2018.07.007. Epub 2018 Jul 24. Indian Heart J. 2018. PMID: 30595242 Free PMC article.
-
Reliability of cheiloscopy and dermatoglyphics in hypertension and diabetes. A comparative study.Ann Afr Med. 2022 Jan-Mar;21(1):77-81. doi: 10.4103/aam.aam_91_20. Ann Afr Med. 2022. PMID: 35313410 Free PMC article.
-
Main characteristics of dermatoglypics associated with schizophrenia and its clinical subtypes.PLoS One. 2021 Jun 10;16(6):e0252831. doi: 10.1371/journal.pone.0252831. eCollection 2021. PLoS One. 2021. PMID: 34111156 Free PMC article.
References
-
- World Health Statistics 2014 [http://www.who.int/gho/publications/world_health_statistics/2014/en/]
-
- World Health Organisation . A global brief on hypertension: silent killer, global public health crises (World Health Day 2013) Geneva: WHO; 2013.
-
- Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J. 2013;2013(34):2159–219. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical